Menitrazepam

Menitrazepam
Systematic (IUPAC) name
5-cyclohex-1-en-1-yl-1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
Identifiers
CAS number	28781-64-8
ATC code	none
PubChem	189875
Chemical data
Formula	C16H17N3O3
Mol. mass	299.32
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

Menitrazepam is a drug which is a benzodiazepine derivative.^[1][2] It is similar in structure to tetrazepam and nimetazepam, with the 7-chloro group of tetrazepam replaced by nitro. It is a hypnotic agent used in the treatment of insomnia, and therefore has strong sedative, anticonvulsant, muscle relaxant, and anxiolytic actions like those of other hypnotic benzodiazepines. Menitrazepam is a good oral hypnotic agent, however, delay in the time for peak plasma levels to reach their maximum brings into question the benefit of menitrazepam for the treatment of insomnia when compared to other hypnotics. Typically, the sleep inducing properties of hypnotics occur within 0.5 hours. In some cases, as with temazepam and nitrazepam, strong hypnotic effects can be felt 15 to 20 minutes after oral ingestion.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it. v • d • e

See also

• Benzodiazepine

References

1. ^ Lundbeck Institute: Psychotropics
2. ^ Volke, J; Ellaithy; Manousek (Apr 1978). "A spectrophotometric and polarographic investigation of three new cyclohexene-substituted benzodiazepines". Talanta 25 (4): 209–13. ISSN 0039-9140. PMID 18962241.